BLB&B Advisors LLC Has $11.47 Million Holdings in Danaher Co. (NYSE:DHR)

BLB&B Advisors LLC trimmed its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 49,945 shares of the conglomerate's stock after selling 2,192 shares during the period. BLB&B Advisors LLC's holdings in Danaher were worth $11,465,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of DHR. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. acquired a new stake in shares of Danaher during the fourth quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new position in Danaher in the 4th quarter valued at approximately $31,000. Teachers Insurance & Annuity Association of America bought a new position in Danaher during the third quarter worth $39,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in shares of Danaher in the 3rd quarter valued at $40,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on DHR shares. Barclays reduced their target price on shares of Danaher from $275.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. TD Cowen boosted their target price on Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target for the company in a research report on Thursday, October 31st. Stephens reaffirmed an "overweight" rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. Finally, Citigroup decreased their price objective on shares of Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $278.00.

Remove Ads

Danaher Price Performance

NYSE:DHR traded up $0.60 during mid-day trading on Wednesday, hitting $202.22. 7,207,744 shares of the company's stock traded hands, compared to its average volume of 4,373,626. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The company has a market cap of $146.06 billion, a PE ratio of 38.30, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The firm's 50 day simple moving average is $231.17 and its 200 day simple moving average is $250.62.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the company posted $2.09 earnings per share. Sell-side analysts expect that Danaher Co. will post 7.67 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. Danaher's dividend payout ratio is currently 20.45%.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.